Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Tempus AI is a healthcare technology company that provides advanced molecular diagnostics and pathology testing, including next-generation sequencing and PCR profiling. They offer a comprehensive data library and analytical services for pharmaceutical and biotech companies, alongside clinical trial matching and research platforms. Tempus AI positions itself as a leader in precision medicine by integrating clinical, molecular, and imaging data to accelerate drug discovery and improve patient care.
AI-generated summary. Not investment advice.